Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial pemphigoid rarely affects the scalp but is hard to treat when it does.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Older people often have untreated genital skin diseases due to embarrassment and lack of medical attention, which can lead to discomfort and even cancer risk.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Old people's nails often have problems due to body changes, more diseases, and self-care difficulties, affecting their movement and hand use.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.